We are live on
!
Find out more
PM
Prosight Management Portfolio holdings
AUM
$610M
1-Year Est. Return
40.86%
This Fund
S&P 500
This Quarter
Est. Return
+6.36%
1 Year Est. Return
+40.86%
3 Year Est. Return
+46.17%
5 Year Est. Return
+1.2%
10 Year Est. Return
–
AUM
$410M
AUM Growth
+$106M
(+35%)
Cap. Flow
+$109M
Cap. Flow
% of AUM
26.67%
Top 10 Holdings %
Top 10 Hldgs %
62.72%
Holding
47
New
9
Increased
19
Reduced
10
Closed
8
Top Buys
| 1 |
UnitedHealth
UNH
|
+$42M |
| 2 |
FOLD
Amicus Therapeutics
FOLD
|
+$13.6M |
| 3 |
LKFT
Lakefront Biotherapeutics American Depositary Shares
LKFT
|
+$12.3M |
| 4 |
Crinetics Pharmaceuticals
CRNX
|
+$9.21M |
| 5 |
Biohaven
BHVN
|
+$7.83M |
Top Sells
| 1 |
Schrodinger
SDGR
|
+$7.6M |
| 2 |
Intuitive Surgical
ISRG
|
+$6.93M |
| 3 |
Mirum Pharmaceuticals
MIRM
|
+$6.38M |
| 4 |
AbCellera Biologics
ABCL
|
+$6.28M |
| 5 |
BridgeBio Pharma
BBIO
|
+$4.99M |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
Acadia Healthcare
ACHC
$2.97B
| $4.81M | 1.17% |
211,816
-78,184
| -27% | -$1.85M |
|
27
Corbus Pharmaceuticals
CRBP
$167M
| $4M | 0.98% |
579,893
+4,757
| +0.8% | +$34.6K |
|
28
Rocket Pharmaceuticals
RCKT
$399M
| $3.87M | 0.94% |
1,580,588
+100,588
| +7% | +$510K |
|
29
Sight Sciences
SGHT
$286M
| $3.6M | 0.88% |
871,687
-97,600
| -10% | -$326K |
|
30
Axogen
AXGN
$2.06B
| $3.07M | 0.75% |
+282,809
| New | +$3.71M |
|
31
Lantheus
LNTH
$6.79B
| $2.83M | 0.69% |
+34,576
| New | +$3.04M |
|
|
MURA
32
DELISTED
Mural Oncology
MURA
| $2.22M | 0.54% |
900,000
+477,257
| +113% | +$1.12M |
|
33
Prothena Corp
PRTA
$441M
| $1.63M | 0.4% |
267,800
-140,322
| -34% | -$1.05M |
|
34
OrthoPediatrics
KIDS
$507M
| $1.58M | 0.39% |
+73,647
| New | +$1.59M |
|
35
Pliant Therapeutics
PLRX
$69.4M
| $971K | 0.24% |
837,400
+503,137
| +151% | +$711K |
|
|
RNTX
36
Rein Therapeutics
RNTX
$80.9M
| $599K | 0.15% |
427,919
-2,081
| -0.5% | -$3.75K |
|
|
OKUR
37
OnKure Therapeutics
OKUR
$170M
| $382K | 0.09% |
159,692
-26,878
| -14% | -$70.5K |
|
38
Erasca
ERAS
$6.61B
| $305K | 0.07% |
240,295
-706,815
| -75% | -$946K |
|
39
PepGen
PEPG
$166M
| $271K | 0.07% |
+243,980
| New | +$345K |
|
|
40
AbCellera Biologics
ABCL
$2.06B
| – | – |
-2,815,652
| Closed | -$6.28M |
|
41
Addus HomeCare
ADUS
$2.06B
| – | – |
-24,045
| Closed | -$2.38M |
|
|
BPMC
42
DELISTED
Blueprint Medicines
BPMC
| – | – |
-36,512
| Closed | -$3.23M |
|
43
Haemonetics
HAE
$3.48B
| – | – |
-65,400
| Closed | -$4.16M |
|
44
Immunome
IMNM
$2.6B
| – | – |
-23,618
| Closed | -$159K |
|
|
45
Intuitive Surgical
ISRG
$138B
| – | – |
-14,000
| Closed | -$6.93M |
|
|
46
Schrodinger
SDGR
$1.22B
| – | – |
-385,000
| Closed | -$7.6M |
|
47
Spyre Therapeutics
SYRE
$8.86B
| – | – |
-74,921
| Closed | -$1.21M |
|
Similar funds
PL
BFC
ACM
FFWA
SAM
CBB
AIG
IA